mRNA COVID-19 vaccination is immunogenic in the immunocompromised
mRNA COVID-19 vaccination is immunogenic in the immunocompromised SHARES Research suggests patients who receive COVID-19 vaccines prior to a transplant and subsequent immunosuppression may be protected from the disease. New research shows that vaccination against SARS-CoV-2 (the virus that causes COVID-19) in immunosuppressed individuals is immunogenic, though to a lesser extent than in the general population. Two studies in thoracic organ transplantation published in the Journal of Heart and Lung Transplantation (JHLT) provide the evidence for such a conclusion. Peled et al. describes 77 v...